The 2020 results include a turnover increase of 110 per cent to £4.6 million, and a near-50 per cent jump in headcount across the group.
Bosses said the results were, in part, attributable to the firm’s response to Covid-19, which has seen existing client demand for its specialist resourcing services increase “dramatically”, while a fifth of the year’s activity has been attributed to new customer wins.
The company has been responsible for placing contract and permanent personnel across the UK, focused upon the development of diagnostics and testing, the manufacture of life-saving technology, laboratory skills and, crucially, the development of Covid vaccines.
Chief commercial director Austin Clark said: “There is no doubt that the circumstances of 2020 have demanded an incredible level of agility and flexibility from those engaged in the search for effective diagnostics, treatment and vaccinations.
“ERS has proven its inherent ability to respond with equal dexterity to a vastly changed landscape where there has been a significant increase in demand for life sciences and associated healthcare contractors.
“We’re incredibly proud of the results we’ve achieved for our UK-wide client base and the part we continue to play in this unique situation.”
The firm has also appointed recruitment business advisory specialist Brian Creegan as interim managing director. He brings some 13 years’ experience in recruitment process optimisation, talent branding and strategic planning.